title: Cryptotanshinione inhibits β-amyloid aggregation and protects damage from β-amyloid in SH-SY5Y cells.
abstract: The deposition of amyloid β-protein (Aβ) fibrils into plaques within the brain parenchyma and along cerebral blood vessels is a hallmark of Alzheimer's disease (AD). Aβ42 oligomers and fibrils cause the breakdown of neural circuits, neuronal death and eventually dementia. Drugs that inhibit Aβ42 aggregation may be a novel direction in AD drug discovery. Cryptotanshinone (CTS), an active component of the medicinal herb Salvia miltiorrhiza, has been shown to improve learning and memory in several pharmacological models of AD. However, the effects of CTS on the Aβ aggregation and toxicity are unclear. The current work shows the effectiveness of CTS on the inhibition of Aβ42 aggregation and toxicity to human neuroblastoma cells. In this study, we demonstrated that CTS can inhibit Aβ42 spontaneous aggregation using thioflavin T fluorescence assay and transmission electron microscopy. Furthermore, we investigated the effects of CTS on Aβ-induced oxidative cell death in cultured SH-SY5Y cells. MTT and lactate dehydrogenase assays showed that CTS reduced the cytotoxicity induced by Aβ42. CTS also dramatically reduced Aβ42-induced cellular apoptosis and increased level of reactive oxygen species in these cells. Our study suggests that CTS may be useful in the inhibition or prevention of AD development and progression.
authors.affiliation: The Third Affiliated Hospital of Guangzhou Medical College, Guangzhou, Guangdong Province, 510150, People's Republic of China.
authors.forename: Zhengrong
authors.initials: Z
authors.lastname: Mei
authors.forename: Pengke
authors.initials: P
authors.lastname: Yan
authors.forename: Bing
authors.initials: B
authors.lastname: Situ
authors.forename: Yonggao
authors.initials: Y
authors.lastname: Mou
authors.forename: Peiqing
authors.initials: P
authors.lastname: Liu
mesh_terms: D016229:Amyloid beta-Peptides / Q000378:metabolism / Q000633:toxicity*; D045744:Cell Line, Tumor; D005434:Flow Cytometry; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D046529:Microscopy, Electron, Transmission; D010616:Phenanthrenes / Q000494:pharmacology*
chemical_list: D016229:Amyloid beta-Peptides; D010616:Phenanthrenes; C037886:cryptotanshinone; D007770:L-Lactate Dehydrogenase
references.citation: Biochemistry. 2009 Dec 8;48(48):11329-31
references.pmid: 19877710
references.citation: J Neurosci. 2010 Mar 3;30(9):3326-38
references.pmid: 20203192
references.citation: Biochemistry (Mosc). 2005 Feb;70(2):231-9
references.pmid: 15807663
references.citation: Eur J Biochem. 1999 Dec;266(3):1101-10
references.pmid: 10583407
references.citation: J Biol Chem. 2003 Sep 26;278(39):37832-9
references.pmid: 12853461
references.citation: Chin Med. 2006 Nov 23;1:3
references.pmid: 17302964
references.citation: J Biol Chem. 1997 Sep 12;272(37):22987-90
references.pmid: 9287293
references.citation: Free Radic Biol Med. 2008 Jun 15;44(12):2019-25
references.pmid: 18387371
references.citation: Curr Drug Metab. 2007 May;8(4):365-78
references.pmid: 17504224
references.citation: J Mol Cell Cardiol. 2004 Oct;37(4):837-46
references.pmid: 15380674
references.citation: Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):330-5
references.pmid: 12506200
references.citation: J Cell Biol. 1998 May 18;141(4):1031-9
references.pmid: 9585420
references.citation: Nat Rev Drug Discov. 2002 Nov;1(11):859-66
references.pmid: 12415246
references.citation: J Immunol. 2008 Nov 15;181(10):7254-62
references.pmid: 18981147
references.citation: J Alzheimers Dis. 2009;17(2):423-40
references.pmid: 19363260
references.citation: Free Radic Res. 2009 Sep;43(9):865-75
references.pmid: 19629817
references.citation: Chembiochem. 2009 Dec 14;10(18):2837-45
references.pmid: 19877000
references.citation: J Neurosci Res. 2008 Aug 1;86(10):2314-25
references.pmid: 18438916
references.citation: Eur J Pharmacol. 2009 Jul 1;614(1-3):91-7
references.pmid: 19401198
references.citation: J Alzheimers Dis. 2008 Apr;13(3):303-21
references.pmid: 18430998
references.citation: Planta Med. 2010 Feb;76(3):228-34
references.pmid: 19774505
references.citation: Prog Neurobiol. 2000 Dec;62(6):633-48
references.pmid: 10880853
references.citation: J Alzheimers Dis. 2010;21(1):35-48
references.pmid: 20182014
references.citation: Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20324-9
references.pmid: 19910533
references.citation: Neuroreport. 2001 Oct 29;12(15):3263-7
references.pmid: 11711868
references.citation: J Biol Chem. 2009 Nov 27;284(48):33400-8
references.pmid: 19679659
references.citation: Curr Neuropharmacol. 2009 Mar;7(1):65-74
references.pmid: 19721819
references.citation: Nat Med. 2002 Nov;8(11):1263-9
references.pmid: 12379850
references.citation: J Biol Chem. 2006 Sep 22;281(38):27916-23
references.pmid: 16870617
references.citation: Food Chem Toxicol. 2009 Jan;47(1):98-103
references.pmid: 19013495
references.citation: Neurochem Res. 2009 Jun;34(6):1120-8
references.pmid: 19030989
references.citation: Neurosci Lett. 2009 Mar 13;452(2):90-5
references.pmid: 19154776
references.citation: Am J Alzheimers Dis Other Demen. 2010 Aug;25(5):414-24
references.pmid: 20601643
references.citation: Exp Mol Med. 2008 Feb 29;40(1):11-8
references.pmid: 18305393